Combined immunotherapy and targeted treatment for primary alveolar soft part sarcoma of the lung: case report and literature review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10637-021-01105-6.pdf
Reference47 articles.
1. Christopherson WM, Foote FW, Stewart FW (1952) Alveolar soft part sarcomas; structurally characteristic tumors of uncertain histogenesis. Cancer 5(1):100–111
2. Soheilifar MH, Taheri RA, Zolfaghari Emameh R et al (2018) Molecular landscape in alveolar soft part sarcoma:implications for molecular targeted therapy. Biomed Pharmacother 103:889–896
3. Mitton B, Federman N (2012) Alveolar soft part sarcomas: molecular pathogenesis and implications for novel targeted therapies. Sarcoma 2012:428789
4. Paoluzzi L, Maki RG (2019) Diagnosis, prognosis, and treatment of alveolar soft part sarcoma: a review. JAMA Oncol 5(2):254–260
5. Trabelsi A, Ben Abdelkrim S, Taher Yacoubi M et al (2009) Sarcome alvéolaire primitif du poumon. Rev Mal Respir 26(3):329–332
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Atezolizumab for Advanced Alveolar Soft Part Sarcoma;New England Journal of Medicine;2023-09-07
2. Efficacy and Safety of Anlotinib-Containing Regimens in Advanced Non-Small Cell Lung Cancer: A Real-World Study;International Journal of General Medicine;2023-09
3. Treatment of a case of primary alveolar soft part sarcoma of the lung: Case report and literature review;Journal of International Medical Research;2023-06
4. Camrelizumab-induced anaphylactic shock in an esophageal squamous cell carcinoma patient: A case report and review of literature;World Journal of Clinical Cases;2022-06-26
5. Long-Term Efficacy and Safety of Anlotinib as a Monotherapy and Combined Therapy for Advanced Sarcoma;OncoTargets and Therapy;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3